Hydroxychloroquine treatment in European patients with lupus erythematosus: dosing, retinopathy screening and adherence.

Zgjim Osmani Thijs J SchramaWendy Zacouris-VerweijJeanette AndersenSusan FrankelIrene E M BultinkAlain CornetRonald F Van Vollenhoven

Published in: Lupus science & medicine (2021)

The results of our study demonstrate that higher than recommended dosages of HCQ are prescribed to more than one-third of patients with lupus in Europe. Recent recommendations regarding screening for retinopathy are incompletely implemented.

Keyphrases

systemic lupus erythematosus
disease activity
rheumatoid arthritis
clinical practice
type diabetes
metabolic syndrome
insulin resistance
replacement therapy